SCHEMBL3743980

SCHEMBL3743980

CCC(Br)(C(=O)O)c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
PTGS2 P35354 1/20 0.41
BLM P54132 2/20 0.40
LMNA P02545 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
NAPRT Q6XQN6 1/20 0.40
P4HTM Q9NXG6 1/20 0.40
CYP2D6 P10635 1/20 0.40
SLC22A2 O15244 1/20 0.40
SLC22A1 O15245 1/20 0.40
PGR P06401 1/20 0.40
THRB P10828 1/20 0.40
ADRB3 P13945 1/20 0.40
OPRK1 P41145 1/20 0.40
PMP22 Q01453 1/20 0.40
KCNH2 Q12809 1/20 0.40
PDE3A Q14432 1/20 0.40
SLC47A1 Q96FL8 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4162402 0.85 BLM (0.45) L3MBTL1SMN1; SMN2PTGS2BLMLMNA
SCHEMBL7828236 0.81 L3MBTL1 (0.47) L3MBTL1SMN1; SMN2PTGS2BLMLMNA
SCHEMBL25500507 0.79 L3MBTL1 (0.46) L3MBTL1SMN1; SMN2PTGS2BLMLMNA
SCHEMBL13269728 0.78 L3MBTL1 (0.44) L3MBTL1SMN1; SMN2PTGS2BLMLMNA
SCHEMBL6418757 0.76 SMN1; SMN2 (0.42) L3MBTL1SMN1; SMN2PTGS2BLMLMNA
SCHEMBL6532232 0.76 SMN1; SMN2 (0.42) L3MBTL1SMN1; SMN2PTGS2BLMLMNA
SCHEMBL262672 0.75 CYP2C19 (0.47) L3MBTL1LMNACYP2D6TSHRALDH1A1
Hydrochloric Acid SCHEMBL17102116 0.75 L3MBTL1 (0.53) L3MBTL1SMN1; SMN2PTGS2BLMLMNA
SCHEMBL9735256 0.74 SMN1; SMN2 (0.41) L3MBTL1SMN1; SMN2PTGS2BLMLMNA
SCHEMBL5074249 0.74 L3MBTL1 (0.52) L3MBTL1SMN1; SMN2PTGS2BLMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R L3MBTL1 4758/4885SMN1; SMN2 3692/4885PTGS2 2215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.